Clinical Investigation of the WaveLight® EX500 Excimer Laser

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

May 2, 2023

Study Completion Date

May 2, 2023

Conditions
HyperopiaHyperopic Astigmatism
Interventions
DEVICE

WaveLight EX500 excimer laser system

FDA approved stationary scanning-spot excimer laser system used during refractive surgery for the treatment of myopia, myopic astigmatism, hyperopia, hyperopic astigmatism, and mixed astigmatism. For this clinical study, the Wavefront Optimized (WFO) Ablation profile of the WaveLight EX500 excimer laser system will be used for bilateral LASIK treatment of hyperopia with and without astigmatism.

PROCEDURE

LASIK

Procedure that reshapes the front part of the eye (cornea) so that light traveling through it is properly focused on the back part of the eye (retina). The procedure will be performed using the WaveLight EX500 excimer laser system.

Trial Locations (5)

27401

Physicians Protocol, Greensboro

58078

Vance Thompson Vision ND, West Fargo

64154

Moyes Eye Center, Kansas City

66210

Durrie Vision, Overland Park

77004

Mann Eye Institute, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT04805593 - Clinical Investigation of the WaveLight® EX500 Excimer Laser | Biotech Hunter | Biotech Hunter